Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy

Claudia Stöllberger1, Josef Finsterer

  • 1Medizinische Abteilung, Krankenanstalt Rudolfstiftung, Vienna, Austria. claudia.stoellberger@chello.at

Clinical Cardiology
|August 8, 2007
PubMed

Insights

Restrictive cardiomyopathy (RCMP) involves impaired heart filling. Investigating underlying systemic diseases is crucial for potential causal therapies beyond managing heart congestion.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathology

Background:

  • Restrictive cardiomyopathy (RCMP) is defined by impaired ventricular filling and reduced diastolic volume, with preserved systolic function.
  • RCMP can be idiopathic or a manifestation of various systemic diseases, including scleroderma, amyloidosis, and sarcoidosis.

Purpose of the Study:

  • To emphasize the importance of investigating extracardiac diseases in patients diagnosed with restrictive cardiomyopathy.
  • To highlight the potential for causal therapy when RCMP is linked to a treatable underlying systemic disorder.

Main Methods:

  • Comprehensive patient evaluation including clinical history, physical examination, and laboratory tests.
  • Systematic assessment of ophthalmologic, otologic, dermatologic, gastroenterologic, nephrologic, hematologic, and neurologic systems.
  • Consideration of endomyocardial biopsy if extracardiac investigations are inconclusive.

Main Results:

  • Idiopathic RCMP management focuses on cardiac congestion relief.
  • Systemic diseases associated with RCMP may offer opportunities for causal treatment.
  • Early detection of underlying causes is vital before the condition becomes untreatable.

Conclusions:

  • Prompt investigation for extracardiac causes is essential upon RCMP diagnosis.
  • Identifying and treating underlying systemic diseases can significantly alter RCMP prognosis.
  • A multidisciplinary diagnostic approach, potentially including endomyocardial biopsy, is key for comprehensive patient care.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...